INS and Hepatic steatosis: Our findings provide novel evidence that higher adherence to the MIND score is significantly associated with reduced severity of MASLD, including lower hepatic steatosis and fibrosis scores, improved insulin sensitivity, reduced systemic inflammation, and favorable gut microbial profiles.